INO
Inovio Pharmaceuticals Inc
NASDAQ: INO · HEALTHCARE · BIOTECHNOLOGY
$1.12
+0.00% today
Updated 2026-04-30
Market cap
$95.46M
P/E ratio
—
P/S ratio
1,460.95x
EPS (TTM)
$-1.81
Dividend yield
—
52W range
$1 – $3
Volume
1.8M
Inovio Pharmaceuticals Inc (INO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $28.98M | $35.95M | $39.78M | $38.99M | $80.63M | $56.07M | $61.11M | $45.14M | $88.29M | $131.79M | $213.84M | $173.71M | $187.24M | $131.11M | $143.95M | $539.77M | $495.94M | $348.53M | $170.95M | $113.20M |
| Cash & equivalents | $17.17M | $8.32M | $10.25M | $14.12M | $30.30M | $20.00M | $17.35M | $5.65M | $33.72M | $40.54M | $57.63M | $19.14M | $23.79M | $23.69M | $22.20M | $250.73M | $71.14M | $46.33M | $14.31M | $65.81M |
| Current assets | $18.32M | $24.47M | $29.00M | $15.26M | $44.57M | $22.88M | $31.91M | $15.97M | $58.68M | $98.95M | $171.85M | $124.60M | $138.36M | $87.81M | $94.20M | $471.17M | $448.44M | $315.24M | $153.11M | $97.83M |
| Total liabilities | $5.51M | $12.45M | $8.74M | $19.88M | $19.44M | $8.97M | $13.24M | $10.28M | $35.38M | $20.25M | $37.91M | $50.33M | $44.75M | $44.08M | $138.55M | $78.63M | $96.27M | $126.17M | $53.60M | $44.69M |
| Current liabilities | $4.14M | $6.86M | $3.35M | $14.71M | $19.35M | $6.44M | $11.04M | $8.38M | $28.97M | $14.09M | $31.47M | $43.82M | $35.41M | $35.30M | $31.99M | $41.71M | $65.74M | $96.87M | $42.57M | $35.33M |
| Long-term debt | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $77.02M | $18.66M | $14.96M | $16.61M | — | — |
| Shareholder equity | $23.47M | $18.15M | $31.03M | $19.11M | $60.56M | $46.50M | $47.31M | $34.35M | $52.46M | $111.23M | $175.69M | $123.28M | $142.39M | $86.94M | $3.44M | $461.14M | $399.67M | $222.36M | $117.35M | $68.50M |
| Retained earnings | $-114.27M | $-128.62M | $-139.85M | $-152.81M | $-177.22M | $-194.84M | $-210.09M | $-229.76M | $-295.79M | $-331.91M | $-361.10M | $-434.84M | $-523.36M | $-620.43M | $-739.79M | $-906.20M | $-1.21B | $-1.49B | $-1.62B | $-1.73B |
| Accounts receivable | $284171.00 | $326071.00 | $1.14M | $671187.00 | $318060.00 | $105036.00 | $506315.00 | $866667.00 | $3.30M | $2.80M | $7.33M | $16.57M | $6.49M | $4.05M | $2.03M | $19.06M | $8.03M | $11.74M | $2.41M | $1.20M |
| Inventory | — | — | — | — | — | — | $0.00 | $62728.00 | $61839.00 | $342573.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Goodwill | $4.29M | $4.29M | $3.90M | $3.90M | $10.11M | $10.11M | $10.11M | $10.11M | $10.11M | $10.11M | $10.11M | $10.51M | $10.51M | $10.51M | $10.51M | $10.51M | $10.51M | $10.51M | $0.00 | — |